Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06933420 · ClinicalTrials.gov registry record · NA
Clinical Protocol CERN Feasibility Study
A NA study of Bacterial Vaginosis and Fungal Vaginal Infections, sponsored by Cern Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 3
- Study locations
NCT06933420 is a NA study of Bacterial Vaginosis and Fungal Vaginal Infections that is actively recruiting participants, run by Cern Corporation. The registered enrollment target is 9 participants, below the 338-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT06933420, a NA study of Bacterial Vaginosis and Fungal Vaginal Infections, is actively recruiting participants, sponsored by Cern Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to learn if the intravaginal Cern device works to treat bacterial vaginosis and fungal vaginitis in premenopausal women. It will also learn about the safety of the device. The main questions it aims to answer are: Does the device accomplish symptom resolution and negative diagnostic tests post-treatment? What medical problems do participants have when using the intravaginal device? Participants will use the investigational intravaginal device for 5 consecutive days, participate in teleconferences and weekly follow-ups, attend in-clinic visits, and maintain a study diary.
Conditions Studied
Interventions
- DEVICE Cern Device
Study Locations (3)
California
- Akerman Med - Irvine
- Akerman Med - Orange
- Akerman Med - Santa Ana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2024-11-06 |
| Est. Completion | 2025-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06933420
The ClinicalTrials.gov registry entry for NCT06933420 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 338-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (97% lower). The listed sponsor is Cern Corporation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bacterial Vaginosis appearing as the primary indexed condition, and to 1 intervention - of which Cern Device is the first listed.
NCT06933420 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06933420 about?
NCT06933420 is a clinical study titled "Clinical Protocol CERN Feasibility Study". The goal of this clinical trial is to learn if the intravaginal Cern device works to treat bacterial vaginosis and fungal vaginitis in premenopausal women. It will also learn about the safety of the device. The main questions it aims to answer are: Does the device accomplish symptom resolution and n...
What is the current status of trial NCT06933420?
This trial is currently recruiting. It is a NA study. The enrollment target is 9 participants. The study started on 2024-11-06. Estimated completion is 2025-05.
What conditions does trial NCT06933420 study?
This clinical trial studies the following conditions: Bacterial Vaginosis, Fungal Vaginal Infections.
What interventions are being tested in trial NCT06933420?
The interventions under investigation include: Cern Device (DEVICE).
Who is sponsoring clinical trial NCT06933420?
This trial is sponsored by Cern Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06933420 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Vaginosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vitamin D and Sexual Health
COMPLETED · NA
-
Flourish HEC to Prevent Recurrence of BV
COMPLETED · NA
-
Prospective Data Bank Creation to Study Vaginal Conditions
RECRUITING
-
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
RECRUITING · Early Phase 1
-
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
ACTIVE NOT RECRUITING · Phase 2
-
Treatment of Bacterial Vaginosis (BV) With Tinidazole
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.